Skip to content

Zoetis ZTS Sheepand Other — Revenue

Discontinued — last reported Q2 '18

Similar metrics at other companies

Elanco Animal Health Inc. logo
ELANFarm Animal Ruminants & Swine — Total Revenue
$397.4M+33.1%
Element Solutions logo
ESIAnimal Health — Revenue
$6.7M-18.3%
Elanco Animal Health Inc. logo
ELANFarm Animal: — Revenue
$642M+17.6%
Elanco Animal Health Inc. logo
ELANFood Animal Ruminants & Swine — Revenue
$158.2M-41.7%
Elanco Animal Health Inc. logo
ELANCattle — Revenue
$316M+16.2%
Elanco Animal Health Inc. logo
ELANCompanion Animal Other — Revenue
$22.5M-3.8%

Other financials

Income statement

See full
Revenue$2.3B+2.9%
Gross profit$1.6B+2.6%
Net income$601.0M-0.2%
EPS (diluted)$1.42+6.0%

Balance sheet

See full
Cash & equivalents$1.9B+8.9%
Total debt$10.0B+48.0%
Total equity$3.2B-30.5%
Total assets$15.2B+7.5%

Cash flow

See full
Operating cash flow$401.0M-22.1%
CapEx$110.0M-38.2%
Free cash flow$291.0M-13.6%

Valuation

See full
Market cap$33B-32.3%
Enterprise value$41.04B-26.4%
P/E12.5×-7.1×
P/S3.5×-1.8×

Profitability

See full
Gross margin71.8%+0.8pp
Net margin27.8%+0.9pp
FCF margin23.5%0.0pp

Returns & leverage

See full
Return on equity67%+15.8pp
Debt / equity3.1×+1.6×
Current ratio3.2×+1.4×

Where this comes from

Reported directly by Zoetis in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Zoetis’s 10-Q, filed August 2, 2018, on SEC EDGAR. View the filing →

Questions, answered.

What does sheepand other — revenue mean?
Total revenue generated from the sale of health products for sheep and other minor animal species.
How do you interpret sheepand other — revenue?
An increase suggests successful market penetration or expanded product adoption in niche livestock segments, while a decrease may indicate reduced demand or competitive pressure in these specialized markets.
How does sheepand other — revenue compare across companies?
Comparable to niche livestock or minor species health product revenue segments reported by other diversified animal health or veterinary pharmaceutical companies.